College of Pharmacy
In this section
In this section
HelixTalk Episode #137 - It’s Time for PBM Reform: How PBMs Have Hurt Pharmacies and Increased Drug Costs
Date posted: October 5, 2021, 6:00 am
In this episode, we reveal what goes on behind the scenes for drug pricing and pharmacy reimbursement with Dr. Benjamin Jolley. Our discussion covers important concepts like PBMs, DIR fees, MAC pricing, and even possible upcoming changes at the federal government.
HelixTalk Episode #136 - Major Recommendations from the 2021 CHEST Anticoagulation for VTE Disease Guideline Updates
Date posted: September 14, 2021, 6:00 am
In this episode, we discuss the recently published major updates in the 9th edition of the anticoagulation guidelines from CHEST. These new recommendations range from initiation of therapy, secondary prevention, and management of post-thrombotic syndrome.
Date posted: August 24, 2021, 6:00 am
In this episode, we debunk four medication myths that have persisted for decades: metronidazole and alcohol; statins and hepatotoxicity; cidal vs. static antibiotics; and "sulfa" allergies.
Date posted: August 3, 2021, 6:00 am
In this episode, we provide a concise review of the diagnostic criteria and general treatment approach to patients with hypertensive emergencies.
Date posted: July 13, 2021, 6:00 am
In this episode, we will explore depths of COVID 19 vaccine hesitancy - what it is, how to identify and address it, and some helpful resources.
HelixTalk Episode #132 - The Warp Speed of Covid-19 Vaccine Authorizations: Timeline and Discussion with Dr. Archana Chatterjee
Date posted: June 22, 2021, 6:00 am
In this episode, we will explore the history of COVID vaccine development and have a heart-to-heart conversation with Dr. Archana Chatterjee regarding her role as a dean of the RFUMS Chicago Medical School, her career path, and her position and functions on the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC).
Date posted: June 1, 2021, 6:00 am
In this episode, we will review the beta-blocker drug class. We discuss their pharmacology, pharmacokinetic/pharmacodynamic parameters, evidence-based use, efficacy, and safety considerations.
HelixTalk Episode #130 - From Pharmacy Student to Clinical Scientist in Pharma: An Interview with Dr. Anastasiya Koshkina
Date posted: May 11, 2021, 6:00 am
In this episode, we discuss pharmaceutical industry career paths with Dr. Anastasiya Koshkina, a graduate of the RFUMS College of Pharmacy and Associate Director and Clinical Scientist at The Janssen Pharmaceutical Companies of Johnson & Johnson.
Date posted: April 20, 2021, 6:00 am
In episode 57, we had in depth discussion of safety issues, general use and recommendations for PPI therapy. In this episode, we briefly review PPI safety concerns and focus on strategies to deprescribe proton pump inhibitors.
Date posted: March 30, 2021, 6:00 am
In this episode, we announce the debut of the HelixTalk Drug Superlative Awards -- awards given to medications on the market that are outstanding or notorious. In announcing these completely fictitious awards, we review key clinical pearls and pitfalls that every clinician should be aware of with these medications.